Output Biosciences Analysis: $125K Raised
What is Output Biosciences?
Output Biosciences develops biologically-aware generative AI to create large biological models for advancing medicine and improving health outcomes.
Employees
5
Founded
2021
Product Features & Capabilities
- Drug Discovery, Biological Data Modeling, Systems Biology, Disease Modeling, Pharmaceutical Research, Drug Candidate Generation, Comprehensive Biological Integration, AI-Enabled Biological Tasks
How much Output Biosciences raised
Pre-Seed - $125,000
August 22, 2021Lead Investor: Y Combinator, Able Partners, First Round Capital, Great Oaks Venture Capital
Who are the founders of Output Biosciences
AM
Adi Mashiach
Co-Founder, CEO
MM
Mirella Mashiach
Co-Founder, COO
Market Focus
Output Biosciences primarily focuses on the biotechnology industry, specifically in the development of biologically-aware generative AI to understand complex biological systems and create breakthrough medicines.
Investors
- Y Combinator
- Able Partners
- First Round Capital
- Great Oaks Venture Capital
Competitors Overview
Output Biosciences operates in the biotechnology sector, focusing on biologically-aware generative AI for drug discovery and understanding complex biological systems. Its main competitors include:
- Insilico Medicine: This company utilizes AI to streamline drug discovery and development proces
Business Model
B2B model leveraging AI for biological insights; revenue from software solutions and partnerships.
See something that needs updating? Suggest edits to this profile.